A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea

BACKGROUND/AIMS: Atrial fibrillation (AF)-related stroke accounts for 20% of ischemic strokes. Rivaroxaban use in AF patients for preventing stroke and systemic embolism was approved in 2013 in Korea. This study was to investigate the safety and effectiveness of rivaroxaban use in Korean patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Jaemin, On, Young Keun, Kwon, Sun U., Nam, Gi-Byoung, Lee, Moon-Hyoung, Park, Hyung-Wook, Hong, Keun-Sik, Kim, Nam-Ho, Amarenco, Pierre, Rha, Seung-Woon, Shin, Dong-Gu, Rha, Joung-Ho, Kim, Young-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273835/
https://www.ncbi.nlm.nih.gov/pubmed/32872740
http://dx.doi.org/10.3904/kjim.2020.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273835/
https://www.ncbi.nlm.nih.gov/pubmed/32872740
http://dx.doi.org/10.3904/kjim.2020.217

Ejemplares similares